John Milligan
Chairman bei PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Dr. John F. Milligan ist Executive Chairman bei 4D Molecular Therapeutics, Inc. und Chairman bei Pacific Biosciences of California, Inc. Er ist Mitglied des Verwaltungsrats der Biotechnology Innovation Organization und der Ohio Wesleyan University. Dr. Milligan war zuvor als President bei Pharmasset, Inc. beschäftigt, als Director-Project Management bei Hoffmann-La Roche, Inc. und als President, Chief Executive Officer & Director bei Gilead Sciences, Inc. Er erhielt seinen Bachelor-Abschluss von der Ohio Wesleyan University und einen Doktortitel von der University of Illinois.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.05.2023 | 100 000 ( 0,20% ) | 3 Mio $ | 31.03.2024 | |
| 24.05.2023 | 110 000 ( 0,04% ) | 412 500 $ | 31.03.2024 |
Aktive Positionen von John Milligan
| Unternehmen | Position | Beginn |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chairman | 14.09.2020 |
| 4D MOLECULAR THERAPEUTICS, INC. | Chairman | 01.08.2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 22.07.2011 |
| Ohio Wesleyan University | Chairman | - |
Ehemalige bekannte Positionen von John Milligan
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Executive Officer | 31.12.2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | President | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Ausbildung von John Milligan
| Ohio Wesleyan University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
